This site is intended for health professionals only

Views

Final Phase IIb interferon-free hepatitis C
Final Phase IIb interferon-free hepatitis C
Patient study demonstrates real-world effectiveness of Galvus®
Patient study demonstrates real-world effectiveness of Galvus®
Statins and diabetes risk
Statins and diabetes risk
CHMP recommends indication for the use of Trajenta®
CHMP recommends indication for the use of Trajenta®
Two CHMP positive opinions for diabetes treatments
Two CHMP positive opinions for diabetes treatments
Global recommendations on ensuring safety of diabetes injections
Global recommendations on ensuring safety of diabetes injections
IMC’s drug-monitoring systems
IMC’s drug-monitoring systems
Mapping neurological disease
Mapping neurological disease
Market access of orphan drugs: one size fits all?
Market access of orphan drugs: one size fits all?
By Steven Simoens and Marc Dooms
Albireo AB liver drug receives positive opinion
Albireo AB liver drug receives positive opinion
Access to Regulatory Focus news and features ‘free for July’
Access to Regulatory Focus news and features ‘free for July’
New pharmacovigilance legislation in operation
New pharmacovigilance legislation in operation
1 … 26 27 28 29 30 … 45


Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x